Ira Winer

2.8k total citations · 1 hit paper
85 papers, 1.8k citations indexed

About

Ira Winer is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Ira Winer has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 27 papers in Reproductive Medicine and 20 papers in Obstetrics and Gynecology. Recurrent topics in Ira Winer's work include Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (18 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Ira Winer is often cited by papers focused on Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (18 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Ira Winer collaborates with scholars based in United States, Canada and Netherlands. Ira Winer's co-authors include David R. Engelke, Cynthia P. Paul, Paul D. Good, Eric R. Fearon, İsmail Mert, Robert Morris, Yali Zhai, Kathleen R. Cho, Guido T. Bommer and Ying Feng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ira Winer

74 papers receiving 1.7k citations

Hit Papers

Effective expression of small interfering RNA in human cells 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effective expression of small interfering RNA in human cells
    2002 661 citations Ira Winer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ira Winer United States 20 971 430 234 231 209 85 1.8k
Caroline E. Ford Australia 27 1.0k 1.1× 647 1.5× 218 0.9× 224 1.0× 296 1.4× 73 2.0k
Chiara Romani Italy 22 498 0.5× 407 0.9× 66 0.3× 493 2.1× 243 1.2× 58 1.6k
Dominique Koensgen Germany 16 848 0.9× 245 0.6× 58 0.2× 185 0.8× 232 1.1× 50 1.3k
Kenzo Sonoda Japan 28 855 0.9× 624 1.5× 96 0.4× 366 1.6× 847 4.1× 86 2.3k
Chiara Casadio Italy 23 342 0.4× 616 1.4× 75 0.3× 118 0.5× 73 0.3× 77 1.8k
Chunsheng Li United States 19 1.3k 1.3× 617 1.4× 112 0.5× 57 0.2× 406 1.9× 32 2.0k
Bart Jonckx Belgium 15 961 1.0× 426 1.0× 54 0.2× 28 0.1× 324 1.6× 24 1.8k
Michael Amatangelo United States 15 1.3k 1.3× 587 1.4× 53 0.2× 81 0.4× 132 0.6× 50 1.9k
David Tacha United States 19 342 0.4× 364 0.8× 157 0.7× 81 0.4× 88 0.4× 37 1.1k
Bruria Shalmon Israel 17 339 0.3× 1.1k 2.6× 214 0.9× 41 0.2× 834 4.0× 31 1.6k

Countries citing papers authored by Ira Winer

Since Specialization
Citations

This map shows the geographic impact of Ira Winer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira Winer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira Winer more than expected).

Fields of papers citing papers by Ira Winer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ira Winer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira Winer. The network helps show where Ira Winer may publish in the future.

Co-authorship network of co-authors of Ira Winer

This figure shows the co-authorship network connecting the top 25 collaborators of Ira Winer. A scholar is included among the top collaborators of Ira Winer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ira Winer. Ira Winer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alvero, Ayesha B., Sharon Wu, Alex Farrell, et al.. (2025). Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis. Gynecologic Oncology. 194. 71–79. 2 indexed citations
3.
Powell, Charles A., Ira Winer, Christopher M. Tarney, Stéphanie Gaillard, & Roisin E. O’Cearbhaill. (2025). Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement. Gynecologic Oncology. 202. 137–145.
4.
Yeku, Oladapo, Minal Barve, Winston Tan, et al.. (2025). Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer. Journal for ImmunoTherapy of Cancer. 13(3). e010959–e010959. 6 indexed citations
5.
Vaishampayan, Ulka N., Jameel Muzaffar, Ira Winer, et al.. (2024). Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1). Journal for ImmunoTherapy of Cancer. 12(11). e010143–e010143. 14 indexed citations
6.
Lee, Eric, Oladapo Yeku, Ira Winer, et al.. (2024). 719MO A phase I/II study of rinatabart sesutecan (Rina-S) in patients with advanced ovarian or endometrial cancer. Annals of Oncology. 35. S550–S550. 3 indexed citations
7.
Tanyi, János L., Leslie M. Randall, Setsuko K. Chambers, et al.. (2023). A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006). Obstetrical & Gynecological Survey. 78(6). 341–342.
8.
9.
Baca, Yasmine, Joanne Xiu, Adam C. ElNaggar, et al.. (2022). Molecular profiles of endometrial cancer tumors among Black patients. Gynecologic Oncology. 166(1). 108–116. 14 indexed citations
10.
Kim, Seongho, et al.. (2021). Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk?. Journal of Minimally Invasive Gynecology. 28(9). 1625–1632. 12 indexed citations
11.
Winer, Ira, et al.. (2021). Neuroendocrine tumors of the gynecologic tract update. Gynecologic Oncology. 162(1). 210–219. 39 indexed citations
12.
Baca, Yasmine, Joanne Xiu, Fábio Távora, et al.. (2020). The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer. Molecular Cancer Therapeutics. 20(1). 183–190. 12 indexed citations
13.
Karpiouk, Andrei, et al.. (2020). Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer Imaging. IEEE photonics journal. 13(1). 1–10. 13 indexed citations
14.
Winer, Ira, Amy Lehman, Jean Wactawski‐Wende, et al.. (2016). Tubal Ligation and Risk of Endometrial Cancer. International Journal of Gynecological Cancer. 26(3). 464–471. 4 indexed citations
15.
Seward, Shelly & Ira Winer. (2015). Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma. Cancer and Metastasis Reviews. 34(1). 5–10. 12 indexed citations
16.
Winer, Ira, İsmail Mert, Subhayu Bandyopadhyay, et al.. (2014). Significance of Lymphovascular Space Invasion in Uterine Serous Carcinoma. International Journal of Gynecological Pathology. 34(1). 47–56. 28 indexed citations
17.
Semaan, Assaad, İsmail Mert, Adnan Munkarah, et al.. (2013). Clinical and Pathologic Characteristics of Serous Carcinoma Confined to the Endometrium. International Journal of Gynecological Pathology. 32(2). 181–187. 21 indexed citations
18.
Mert, İsmail, Assaad Semaan, Ira Winer, Robert Morris, & Rouba Ali‐Fehmi. (2013). Vulvar/Vaginal Melanoma. International Journal of Gynecological Cancer. 23(6). 1118–1125. 33 indexed citations
19.
20.
Kolligs, Frank T., Marvin T. Nieman, Ira Winer, et al.. (2002). ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation. Cancer Cell. 1(2). 145–155. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline E. Ford Breakdown of academic impact, for papers by Chiara Romani Breakdown of academic impact, for papers by Dominique Koensgen Breakdown of academic impact, for papers by Kenzo Sonoda Breakdown of academic impact, for papers by Chiara Casadio Breakdown of academic impact, for papers by Chunsheng Li Breakdown of academic impact, for papers by Bart Jonckx Breakdown of academic impact, for papers by Michael Amatangelo Breakdown of academic impact, for papers by David Tacha Breakdown of academic impact, for papers by Bruria Shalmon
Rankless by CCL
2026